The non-invasive aesthetic treatment market provides patients with various body contouring and skin rejuvenating cosmetic procedures without surgery or downtime. Treatments like laser liposuction, cellulite reduction therapy, non-surgical fat reduction, skin tightening and wrinkle reduction help enhance facial and body aesthetics through minimally invasive techniques.
The Global Non-Invasive Aesthetic Treatment Market Demand is estimated to be valued at US$ 35.42 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the non-invasive aesthetic treatment market are Cutera, Galderma, Lumenis, Hologic, Merz Pharma GmbH & Co. KGaA, Cynosure, Revance Therapeutics Inc., Syneron Candela, Bausch Health Companies Inc., Johnson & Johnson, Solta Medical, Sientra, Fotona, Sisram Medical, BTL Aesthetics. The rising demand for beauty treatments among millennials and working professionals along with the growing preference for minimally invasive procedures have boosted the non-invasive aesthetic treatment industry. Additionally, increasing awareness about aesthetic procedures and their availability across worldwide locations has further contributed to the global expansion of the non-invasive aesthetic treatment market.
Market key trends
One of the key trends witnessed in the non-invasive aesthetic treatment market is the rising demand for energy-based non-invasive procedures. Treatments like laser therapy, radiofrequency, ultrasound, infra-red light and low-level laser therapy are gaining popularity as they help reduce fat, tighten skin without surgery. These procedures stimulate collagen production, destroy fat cells and wrinkles to provide contouring and rejuvenating effects. The advantages of being needle-free, with minimal pain and quick recovery has driven the adoption of energy-based techniques in the non-invasive aesthetic treatment market.
Porter’s Analysis
Threat of new entrants: High capital requirements and need for regulatory approvals pose high entry barriers for new players.
Bargaining power of buyers: Buyers have high bargaining power due to availability of treatment options from multiple providers.
Bargaining power of suppliers: Suppliers face moderate bargaining power of buyers as suppliers have differentiated products.
Threat of new substitutes: Threat of substitutes is moderate as new alternative treatments keep emerging.
Competitive rivalry: Intense competition exists among existing players to gain higher market share.
Geographical Regions
North America accounts for the largest market share currently, with the US being the major revenue generator. Growing awareness about aesthetic procedures and rising disposable incomes drive the market in the region.
The Asia Pacific region is expected to witness the fastest growth over the forecast period owing to rapidly growing medical tourism industry in countries like India, Thailand and China. Rising standards of living and increasing willingness to spend on aesthetic treatments offer high growth potential in the Asia Pacific non-invasive aesthetic treatment market.
Europe holds the second largest market share globally led by Germany, France and the UK. Well established healthcare infrastructure coupled with growing preference for minimally invasive procedures augment the European non-invasive aesthetic treatment industry.
Preference for non-surgical treatments over invasive surgeries drives the non-invasive aesthetic treatment adoption in Latin American countries such as Brazil and Mexico. The Middle East & Africa region presents lucrative prospects for industry players driven by increasing medical aesthetics demand and availability of advanced facilities.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it